Feedback / Questions
Undisclosed 20S proteasome activator for parkinson’s disease - Booster Therapeutics
https://www.businesswire.com/news/home/20251113551272/en/Booster-Therapeutics-Awarded-Grant-from-The-Michael-J.-Fox-Foundation-for-Parkinsons-Research-MJFF-to-Advance-New-Class-of-Proteasome-Activator-Medicines-Towards-First-in-Human-Phase-1-Study
 
Nov 13, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious